Kyorin Holdings Inc
TSE:4569

Watchlist Manager
Kyorin Holdings Inc Logo
Kyorin Holdings Inc
TSE:4569
Watchlist
Price: 1 537 JPY -1.16% Market Closed
Market Cap: 88.3B JPY

Relative Value

The Relative Value of one Kyorin Holdings Inc stock under the Base Case scenario is hidden JPY. Compared to the current market price of 1 537 JPY, Kyorin Holdings Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Kyorin Holdings Inc Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
87
vs Industry
76
Median 3Y
0.8
Median 5Y
0.9
Industry
2.6
Forward
0.7
vs History
85
vs Industry
20
Median 3Y
18.1
Median 5Y
19.5
Industry
21.4
Forward
17.4
vs History
82
vs Industry
6
Median 3Y
25.3
Median 5Y
25.1
Industry
16.4
vs History
0
vs Industry
Median 3Y
-12.7
Median 5Y
-19.1
Industry
22.8
vs History
82
vs Industry
68
Median 3Y
0.7
Median 5Y
0.8
Industry
2.2
vs History
87
vs Industry
74
Median 3Y
0.8
Median 5Y
0.8
Industry
2.9
Forward
0.7
vs History
79
vs Industry
70
Median 3Y
1.7
Median 5Y
1.7
Industry
5.5
vs History
87
vs Industry
29
Median 3Y
8.7
Median 5Y
8.8
Industry
13
Forward
8.8
vs History
87
vs Industry
19
Median 3Y
14.4
Median 5Y
15.8
Industry
16.5
vs History
73
vs Industry
7
Median 3Y
27.5
Median 5Y
22.2
Industry
15.6
vs History
9
vs Industry
Median 3Y
-19.8
Median 5Y
-19.8
Industry
18.7
vs History
84
vs Industry
68
Median 3Y
0.6
Median 5Y
0.6
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Kyorin Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Kyorin Holdings Inc
TSE:4569
88.3B JPY 0.7 9.5 5.5 7.5
US
Eli Lilly and Co
NYSE:LLY
1T USD 17.2 55.5 37.2 39.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
498.9B USD 5.4 19.9 16.2 21.1
CH
Roche Holding AG
SIX:ROG
261.4B CHF 4.2 27.7 11.8 13.8
UK
AstraZeneca PLC
LSE:AZN
210.8B GBP 4.9 30.2 108.3 158.6
CH
Novartis AG
SIX:NOVN
210.3B CHF 4.7 18.4 11.7 15.1
US
Merck & Co Inc
NYSE:MRK
264.8B USD 4.1 13.9 9.9 11.7
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK 4.6 14.1 9.9 11.5
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
143.2B USD 2.3 14.6 7.4 10.2
P/E Multiple
Earnings Growth PEG
JP
Kyorin Holdings Inc
TSE:4569
Average P/E: 22.6
9.5
-20%
N/A
US
Eli Lilly and Co
NYSE:LLY
55.5
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.9
29%
0.7
CH
Roche Holding AG
SIX:ROG
27.7
29%
1
UK
AstraZeneca PLC
LSE:AZN
30.2
37%
0.8
CH
Novartis AG
SIX:NOVN
18.4
17%
1.1
US
Merck & Co Inc
NYSE:MRK
13.9
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
14.1
3%
4.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
27%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
Kyorin Holdings Inc
TSE:4569
Average EV/EBITDA: 400.3
5.5
-16%
N/A
US
Eli Lilly and Co
NYSE:LLY
37.2
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.2
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.8
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
108.3
10%
10.8
CH
Novartis AG
SIX:NOVN
11.7
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.9
6%
1.6
DK
Novo Nordisk A/S
CSE:NOVO B
9.9
1%
9.9
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
Kyorin Holdings Inc
TSE:4569
Average EV/EBIT: 1 712.8
7.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.9
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.1
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.8
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
158.6
23%
6.9
CH
Novartis AG
SIX:NOVN
15.1
12%
1.3
US
Merck & Co Inc
NYSE:MRK
11.7
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
11.5
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.2
7%
1.5